Contract notice
Section I: Contracting
authority
I.1) Name and addresses
University Hospitals of Derby and Burton NHS Foundation Trust
Royal Derby Hospital, Uttoxeter Road
Derby
DE22 3NE
UK
Contact person: Jane Brailsford
E-mail: jane.brailsford1@nhs.net
NUTS: UKF11
Internet address(es)
Main address: https://www.uhdb.nhs.uk
Address of the buyer profile: https://www.uhdb.nhs.uk
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://health-family.force.com/s/Welcome
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be sent to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://health-family.force.com/s/Welcome
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
Reference number: Atamis Ref: C300552 - Tender Ref D95
II.1.2) Main CPV code
85100000
II.1.3) Type of contract
Services
II.1.4) Short description
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the ‘Service’ to Participating Purchasing Authorities
II.1.5) Estimated total value
Value excluding VAT:
2 760 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKF
Main site or place of performance:
Member Trusts of the East Midlands Pharmacy Collaborative - EAST MIDLANDS
II.2.4) Description of the procurement
This Tender will review the use of Parenteral Chemotherapy (plus associated therapies) and for Parenteral Biologics Inc. Immunotherapies within the East Midlands and look to provide a cost/service improvement through an Open Tender process. This contract outlines the provision of a dispensing/compounding and delivery service to patients’ homes for Parenteral Chemotherapy plus associated treatments and for Parenteral Biologics plus nursing support where required, for administration for all products.<br/>The Supplier must provide a comprehensive Homecare service for provision of Parenteral Chemotherapy plus associated treatments and for Parenteral Biologics Inc. Immunotherapies for the member Purchasing Authority’s in accordance with the agreed contract and legal requirements which comprises: <br/>(i) Compounding, dispensing, delivery and administration of Parenteral Chemotherapy plus associated supportive medicines and for Parenteral Biologics in a syringe or infusion bag or administration device (approved by an individual Purchasing Authority or collectively via all participating Purchasing Authority’s) with provision of a nurse to administer all doses.<br/>(ii) Pharma Funded schemes, where covered by the general service descriptor, will fall under this tender for the service element until such time a Nationally Agreed service specification for Pharma schemes is approved and adopted by both Pharma and the NHS.<br/>(iii) Unlicensed Imported medicines are subject to a locally signed technical agreement for the provision of the product and the provision of such products are not covered by this tender.<br/>(iv) For unlicensed medicines, the Purchasing Authority will stipulate the specific brand and product details to the Supplier.<br/>(v) Notwithstanding the above point regarding unlicensed imported medicines, where the Purchasing Authority chooses to use such product, the service element of this contract and all obligations around provision of that service are specifically covered in this specification and should be included in any resulting agreement.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
2 760 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
01/05/2025
End:
30/04/2027
This contract is subject to renewal: Yes
Description of renewals:
At the discretion of the Contracting Authority and the Supplier/s
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
This Framework agreement may extend to all National Health Service (NHS) bodies in England, including but not limited to:<br/>The Purchasing Collaborative Organisations that are listed under The Specialist Pharmacy Service may participate in this Framework during the Contract period. Please see the current list at: https://www.sps.nhs.uk/articles/collaborative-purchasing-organisations/<br/>(https://www.sps.nhs.uk/articles/collaborative-purchasing-organisations/)<br/>NHS Provider Directory: https://www.england.nhs.uk/publication/nhs-provider-directory/<br/>(https://www.england.nhs.uk/publication/nhs-provider-directory/) NHS Foundation Trusts at:<br/>https://www.england.nhs.uk/wp-<br/>content/uploads/2019/04/Public_Registry_FT_directory_190403.xls<br/><br/>The value of this Framework may increase during the 4 year period depending on Contract take up by the members listed in this Contract Notice
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:
As per the Invitation to Tender documents
III.1.2) Economic and financial standing
List and brief description of selection criteria:
As per the Invitation to Tender documents
Minimum level(s) of standards required:
As per the Invitation to Tender documents
III.1.3) Technical and professional ability
List and brief description of selection criteria:
As per the Invitation to Tender documents
Minimum level(s) of standards required:
As per the Invitation to Tender documents
III.2) Conditions related to the contract
III.2.2) Contract performance conditions
As per the Invitation to Tender documents
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement with several operators.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
11/10/2024
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
IV.2.7) Conditions for opening of tenders
Date:
14/10/2024
Local time: 09:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
Yes
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.3) Additional information
This Framework agreement may extend to all National Health Service (NHS) bodies in England, including but not limited to:<br/>The Purchasing Collaborative Organisations that are listed under The Specialist Pharmacy Service may participate in this Framework during the Contract period. Please see the current list at: https://www.sps.nhs.uk/articles/collaborative-purchasing-organisations/<br/>(https://www.sps.nhs.uk/articles/collaborative-purchasing-organisations/)<br/>NHS Provider Directory: https://www.england.nhs.uk/publication/nhs-provider-directory/ (https://www.england.nhs.uk/publication/nhs-provider-directory/) NHS Foundation Trusts at:<br/>https://www.england.nhs.uk/wpcontent/uploads/2019/04/Public_Registry_FT_directory_190403.xls
VI.4) Procedures for review
VI.4.1) Review body
East Midlands Pharmacy Collaborative
London Road
Derby
DE1 2QY
UK
Internet address(es)
URL: https://www.uhdb.nhs.uk/contact-us-florence-nightingale-community-hospital/
VI.4.2) Body responsible for mediation procedures
East Midlands Pharmacy Collaborative
London Road
Derby
DE1 2QY
UK
Internet address(es)
URL: https://www.uhdb.nhs.uk/contact-us-florence-nightingale-community-hospital/
VI.5) Date of dispatch of this notice
09/08/2024